Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balstilimab alone or with zalifrelimab for advanced cervical cancer
CTR20211989Phase 2Active
- Sponsor
- Agenus Inc.
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of balstilimab, zalifrelimab in Cervical Cancer (CC), sponsored by Agenus Inc.. Started Aug 2021; status: active.
02
Drugs
balstilimabzalifrelimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on CTR20211989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211989.